Vnitr Lek 2022, 68(7):461-464 | DOI: 10.36290/vnl.2022.097

Therapy of hypertension in elderly population and its potential risks

Jiří Widimský
III. interní klinika VFN a 1. LF UK Praha

Arerial hypertension is comon in subjects ≥ 65 years old and includes in majority of subjects systolic/diastolic form or isolated systolic hypertension. Basic therapeutic principles to the therapy of hypertension of elderly subjects are summarized. Slow and careful uptitration of antihypertensive therapy is recommended. Potential complications and caveats of therapy are also discussed, which are especially related to older frail subjects. Pharmacotherapy of hypertension in elderly is in vast majority of subjects highly beneficial with decrease of cardiovascular (CV) events and CV mortality.

Keywords: arterial hypertension, elderly, therapy, risk, benefit.

Accepted: October 17, 2022; Published: October 31, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J. Therapy of hypertension in elderly population and its potential risks. Vnitr Lek. 2022;68(7):461-464. doi: 10.36290/vnl.2022.097.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-13. Go to original source... Go to PubMed...
    2. Kannel WB, Wolf PA, McGee DL et al. Systolic blood pressure, arterial rigidity and stroke. The Framingham study. JAMA. 1981;245:1225-8. Go to original source... Go to PubMed...
    3. Psaty BM, Furberg CD, Kuller LH. et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med. 2001;161:1183-92. Go to original source... Go to PubMed...
    4. Benetos A, Thomas F, Bean K et al. Prognostic value of systolic and diastolic blood pressure in treated hypertensive patients. Arch Intern Med. 2002;162:577-81. Go to original source... Go to PubMed...
    5. The Task Force for the management of arterial hypertension of the European. Society of Cardiology and the European Society of Hypertension. ESH/ESC guidelines for the management of arterial hypertension: J Hypertens. 2018;36:1953-2041.
    6. Widimský J jr., Filipovský J, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2017. Doporučení České společnosti pro hypertenzi Vnitřní lékařství 2018,7-8,771-796.
    7. Beckett NS, Peters R, Fletcher AE et al. for the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. Go to original source... Go to PubMed...
    8. Williamson JD, Supiano MA, Applegate WB et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years. A randomized clinical trial. JAMA. 2016; doi:10.1001/jama.2016.7050. Go to original source... Go to PubMed...
    9. Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older subjects. Circ. Res. 2019,124,1045-1060. Go to original source... Go to PubMed...
    10. Butt DA, Harvey PJ. Benefits and risks of antihypertensive medications inthe elderly J. Intern Med. 2015;278:599-626. Go to original source... Go to PubMed...
    11. Mohandas R, Chamarthi G, Bozorgmehri S et al. Pro Re Nata Antihypertensive Medications and Adverse Outcomes in Hospitalized Patients: A Propensity‑Matched Cohort Study. Hypertension. 2021;78:516-524. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.